Cantel Medical Corp. (NYSE: CMD) reported Q3 EPS of $0.51, in-line with the analyst estimate of $0.51. Revenue for the quarter came in at $192.11 million versus the consensus estimate of $194.85 million.

For earnings history and earnings-related data on Cantel Medical Corp. (CMD) click here.